[go: up one dir, main page]

MX2017008454A - Peptidos y su uso en el tratamiento de la piel. - Google Patents

Peptidos y su uso en el tratamiento de la piel.

Info

Publication number
MX2017008454A
MX2017008454A MX2017008454A MX2017008454A MX2017008454A MX 2017008454 A MX2017008454 A MX 2017008454A MX 2017008454 A MX2017008454 A MX 2017008454A MX 2017008454 A MX2017008454 A MX 2017008454A MX 2017008454 A MX2017008454 A MX 2017008454A
Authority
MX
Mexico
Prior art keywords
peptides
skin
treatment
compositions
growth
Prior art date
Application number
MX2017008454A
Other languages
English (en)
Other versions
MX389490B (es
Inventor
Santhanam Uma
Idkowiak Baldys Jolanta
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of MX2017008454A publication Critical patent/MX2017008454A/es
Publication of MX389490B publication Critical patent/MX389490B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)

Abstract

Realizaciones de la invención se refieren generalmente a los métodos de disminuir los signos de envejecimiento en y/o mejorar la salud de integumentos humanos tales como la piel, y a composiciones que comprenden péptidos útiles para ello. Las composiciones de acuerdo con la invención pueden comprender uno o más péptidos o fragmentos o derivados de los mismos derivados de un factor de crecimiento, p. ej., Factor de Diferenciación de Crecimiento 11 (GDF11) en un vehículo tópicamente aceptable.
MX2017008454A 2014-12-23 2015-09-03 Peptidos y su uso en el tratamiento de la piel. MX389490B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462095873P 2014-12-23 2014-12-23
PCT/US2015/048240 WO2016105607A1 (en) 2014-12-23 2015-09-03 Peptides and their use in the treatment of skin

Publications (2)

Publication Number Publication Date
MX2017008454A true MX2017008454A (es) 2017-10-31
MX389490B MX389490B (es) 2025-03-20

Family

ID=56128191

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008454A MX389490B (es) 2014-12-23 2015-09-03 Peptidos y su uso en el tratamiento de la piel.

Country Status (10)

Country Link
US (1) US10034826B2 (es)
EP (1) EP3236992B1 (es)
CN (1) CN107106652A (es)
BR (1) BR112017013696B1 (es)
CA (1) CA2972015A1 (es)
MX (1) MX389490B (es)
PH (1) PH12017501070B1 (es)
RU (1) RU2709778C2 (es)
WO (1) WO2016105607A1 (es)
ZA (1) ZA201704726B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101810385B1 (ko) * 2016-02-04 2017-12-20 주식회사 강스템바이오텍 Gdf11을 포함하는 조성물 및 그의 용도
US11766467B2 (en) 2017-09-01 2023-09-26 University Of Wyoming Methods of treating wounds using cathepsin K inhibitors
US10758559B1 (en) 2017-09-01 2020-09-01 University Of Wyoming Targeting cathepsin K to facilitate wound healing
EP3682891A4 (en) 2017-09-15 2021-07-21 Kine Sciences Co., Ltd. USE OF PEPTIDES AS A THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES AND BONE DISEASES
CN108586575B (zh) * 2018-04-11 2020-08-14 福建省中科生物股份有限公司 一种多肽及其皮肤修复功能的应用
PT3906012T (pt) 2019-01-04 2022-11-28 Avon Prod Inc Derivados oxidados de fragmentos de gdf-11
JP2022530036A (ja) * 2019-04-24 2022-06-27 フォリクム エービー 局所製剤
WO2022051831A1 (pt) * 2020-09-11 2022-03-17 Chemyunion Ltda. Composição, uso de composição, método cosmético e método para modular a produção de sebo
KR20240133853A (ko) * 2023-02-28 2024-09-05 루다큐어 주식회사 신규 펩타이드 및 이의 용도

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
US20030167492A1 (en) 1994-07-08 2003-09-04 Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same
AU2368601A (en) * 1999-12-22 2001-07-03 Polymun Scientific Immunobiologische Forschung Gmbh Bioactive oligopeptides
JP2005507904A (ja) 2001-10-05 2005-03-24 プロサイト コーポレイション ペプチド銅錯体およびレチノール、レチノール誘導体、またはそれらの混合物を含むスキンケア組成物
CA2484941A1 (en) 2002-07-24 2004-02-05 Intercell Ag Antigens encoded by alternative reading frame from pathogenic viruses
US7504092B2 (en) * 2002-11-08 2009-03-17 Isp Investments Inc. Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
US7141544B2 (en) * 2003-10-10 2006-11-28 Baxter International, Inc. Stabilization of pharmaceutical protein formulations with small peptides
US9387235B2 (en) * 2004-06-14 2016-07-12 Basf Beauty Care Solutions France S.A.S. Cosmetic preparations containing PTH fragments
TWI415628B (zh) 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
US20100047299A1 (en) 2007-01-25 2010-02-25 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Use of gdf-5 for the improvement or maintenance of dermal appearance
US8987212B2 (en) 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
CN101990425B (zh) * 2008-04-08 2016-01-20 默克专利股份有限公司 包含环肽的组合物和使用方法
CN102471769A (zh) * 2009-07-17 2012-05-23 亚伦·T.·塔波尔 用于具有美容功能的细胞的遗传修饰以提高美容外观的方法和组合物
WO2011063165A1 (en) * 2009-11-18 2011-05-26 Affinergy, Inc. Methods and compositions for capture of cells
EP3042665A1 (en) * 2009-12-28 2016-07-13 N.V. Perricone LLC Cosmetic method for improving the signs of skin aging by using a topical acyl glutathione formulation
CN101884602A (zh) * 2010-03-03 2010-11-17 孙杰 一种皮肤美容修复抗衰除皱的化妆品制剂
KR20130052441A (ko) 2011-11-11 2013-05-22 (주) 코웰메디 재조합 인간 골형성 단백질과 트위스트 전사인자를 활성성분으로 함유하는 피부조직 재생용 조성물 및 키트
JP2015516143A (ja) 2012-04-02 2015-06-08 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ヒト疾患に関連するタンパク質の産生のための修飾ポリヌクレオチド
FR2998570B1 (fr) * 2012-11-26 2016-12-02 Sederma Sa Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
KR102276326B1 (ko) * 2013-03-13 2021-07-13 앙테이스 에스.아. 피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법
CA2942478A1 (en) 2013-03-13 2014-10-02 Stemetrix, Inc. Skin compositions and uses
ITRM20130199A1 (it) 2013-04-03 2014-10-04 Irbm Science Park S P A Peptidi per uso dermatologico e/o cosmetico
EP4140497A1 (en) * 2013-04-08 2023-03-01 President and Fellows of Harvard College Compositions for rejuvenating skeletal muscle stem cells
US9125843B2 (en) * 2013-10-03 2015-09-08 Elc Management Llc Methods and compositions for improving the appearance of skin
US20170281507A1 (en) * 2014-12-23 2017-10-05 Avon Products, Inc. Peptides and Their Use in the Treatment of Skin
WO2016105365A1 (en) * 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
US20170304178A1 (en) * 2014-12-23 2017-10-26 Avon Products, Inc. Peptides and Their Use in the Treatment of Skin
US9597274B2 (en) * 2015-06-17 2017-03-21 Avon Products, Inc. Peptides and their use in the treatment of skin

Also Published As

Publication number Publication date
PH12017501070B1 (en) 2022-04-29
RU2709778C2 (ru) 2019-12-20
PH12017501070A1 (en) 2017-12-11
EP3236992C0 (en) 2025-10-29
MX389490B (es) 2025-03-20
CN107106652A (zh) 2017-08-29
BR112017013696A2 (pt) 2018-02-06
EP3236992B1 (en) 2025-10-29
EP3236992A1 (en) 2017-11-01
BR112017013696B1 (pt) 2024-01-02
WO2016105607A1 (en) 2016-06-30
RU2017123388A3 (es) 2019-01-25
US10034826B2 (en) 2018-07-31
ZA201704726B (en) 2019-01-30
US20160175225A1 (en) 2016-06-23
CA2972015A1 (en) 2016-06-30
RU2017123388A (ru) 2019-01-24
EP3236992A4 (en) 2018-09-05

Similar Documents

Publication Publication Date Title
MX2017008454A (es) Peptidos y su uso en el tratamiento de la piel.
EP4620519A3 (en) Methods and compositions relating to chondrisomes from blood products
MX2022012374A (es) Composiciones multi-suplementos.
MX2019011764A (es) Composiciones limpiadoras y usos de las mismas.
PH12017502255B1 (en) Nrf2 regulators
BR112016028891A2 (pt) processos de trens de sementes e usos dos mesmos
MX385845B (es) Usos y composiciones de la flagelina
MY193650A (en) Extracellular matrix compositions
MX2017006113A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2017012595A (es) Un extracto de indigo naturalis y un proceso para preparar el mismo.
BR112018014590A2 (pt) formulações/composições compreendendo um inibidor de btk
MX390126B (es) Nuevas isoformas de tripsina y su uso.
GT201500143A (es) Composiciones que comprenden vortioxetina y donepezilo campo tecnico
CL2016002839A1 (es) Derivados de carboxamida
MX2016012784A (es) Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones.
SV2017005585A (es) Peptidos lipidados resistentes a proteasas
WO2016020210A8 (en) Factor viii formulation
WO2016094374A8 (en) Compositions and methods for treatment of friedreich's ataxia
MX383947B (es) Composiciones de colágeno 7 y métodos para usar las mismas.
MX383460B (es) Derivados peptidicos novedosos y sus usos.
MX375918B (es) Composiciones para el tratamiento de la fibrosis y afecciones relacionadas con la fibrosis.
MX378539B (es) Analagos de apelina ciclicos.
UY35600A (es) "composiciones farmacéuticas que comprenden compuestos derivados de triazolopiridina y métodos para prepararlas"
EA201791388A1 (ru) Общий синтез триоксакарцина dc-45-a2 и получение аналогов триоксакарцина